Position
Citadel in Collegium Pharmaceutical, Inc
Back to the book · All holders of COLL
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $214.7K$33.07 → $36.20
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 131.1K | $6.07M | — | — | — | 0.0% |
| Q1 2026 | 121.4K | $4.01M | $33.07 | −$1.61M | −$451.9K | 0.0% |
| Q2 2026 | 68.6K | $2.48M | $36.20 | $214.7K | −$1.75M | 0.0% |